Essential Skills in Pharmaceutical Compounding: Non-Sterile Technician Training
The Practice-based activity will provide compounding technicians with the competency to prepare current and viable pharmacotherapeutic
non-sterile dosage forms. Unique concepts will be taught facilitating a superior level of knowledge and understanding of the significance
and importance of pharmacy compounding.
A significant emphasis will be placed on quality assurance and quality control as it relates to the preparation of compounded dosageforms,
pharmaceutical calculations and the validation of preparatory procedures that are a part of Master Formulation Records. Practical
techniques and technology-related applications are developed through hands-on experience in a compounding laboratory environment
where technicians will be trained in all aspects of non-sterile preparatory procedures.
Technicians with professional interest in performing pharmacy compounding.
A two part activity; self-study with learning assessment and live event with competency assessment.
The duration of this course is 16 hours.
OVERALL LEARNING OBJECTIVES OF SELF-STUDY ACTIVITY
- Describe non-sterile compounding-related Australian and USP guidelines and related standards of practice.
- Identify excipients and their functions in non-sterile dosage form-related delivery systems.
- Explain process validation techniques related to specific dosage-forms.
- Demonstrate pharmaceutical calculations related to specific dosage-forms and preparatory procedures.
- Identify laboratory practices, procedures and preparatory techniques related to compounded dosage-forms.
- Summarize a broad range of non-sterile preparatory procedures representing commonly compounded dosage-forms.
OVERALL LEARNING OBJECTIVES OF LIVE ACTIVITY
- Apply Australian and USP regulatory guidlines and Professional Practice Standards (Australia) to measurable compoundingrelated performance.
- Perform process validation techniques related to specific dosage-forms.
- Perform pharmaceutical calculations related to specific dosage-forms and preparatory procedures.
- Prepare a broad range of non-sterile preparations representing commonly compounded dosage-forms; capsules, troches, ointments, creams, lotions, gels and suppositories.
CPD Coordinator and Compounding Pharmacist, MEDISCA Australia.
NEIL COHEN, BSc
CE Coordinator, LP3 Network Inc.
CONTRIBUTORS / FACILITATORS
Tammy Nguyen, B Pharm
Compounding Pharmacist, Bova Compounding Chemist; MEDISCA Australia, Consultant.
Rebecca O'Grady, B Pharm, GradCertPharmPrac
Technical Support Services Representative, MEDISCA Australia.
Patricia Ullmann, B Pharm
Compounding Pharmacist, MEDISCA Australia.
Activity material is Copyright© 2012-2019 LP3 Network Inc.
Activity participants are required to achieve a 75% passing grade associated with a self-study learning assessment prior to attending the live event.
Activity participants must be in attendance for the entire live event and complete an activity evaluation as compulsory requirements to achieve
credit for the live event.
DECLARATIONS AND DISCLOSURES
The MEDISCA Group of Companies believes it is important for the reader to be aware of relevant affiliations and financial relationships regarding
the development, design and facilitation of this activity and its financial supporter and the financial supporter’s affiliates. MEDISCA Australia
assists with the marketing of this activity. LP3 Network Inc. is an independent corporation. LP3 Network Inc. has an established agreement with
MEDISCA Inc. ensuring that it has no influence on LP3 Network Inc. as it relates to activity offerings.
An unrestricted educational grant has been provided by MEDISCA Australia toward the purchase of electromechanical equipment, reusable
and disposable devices, protective and safety supplies, and chemicals specific to compounded medications prepared during laboratory sessions.
Special rates for hotel accommodations have been arranged for activity participants. Payment for hotel accommodations is at the expense of the
FOOD AND BEVERAGE
As a matter of activity programming, meals and refreshments during live activities have been provided by MEDISCA Australia.
CANCELLATION AND REFUND POLICY
A written request must be sent to LP3 Network Inc. requesting a ‘Cancellation without Transfer’ to an alternate live activity event date. If
cancellation occurs at greater than or equal to 31 days from the live activity event date, then the registrant will receive a 75% refund; 15-30 days
is a 50% refund; and less than or equal to 14 days will result in no refund.
The transfer policy is only in effect if requested greater than or equal to 14 days prior to original live activity event date. Failure to submit the
“Transfer Request” at least 14 days prior to original live activity event date will default to the “Cancellation and Refund Policy”. The transfer policy
can only be applied one (1) time. Transfer to a new live activity event date must be within the current calendar year. Failure to attend the new
live activity event will result in no refund and will no longer be transferable. Confirmation of the new activity date is subject to approval by LP3
Network Inc. based on the number of available seats within the selected live activity event.